Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria | Zendy

Srujana Mohanty | Zendy; Rajni Gaind | Zendy; Rajeev Ranjan | Zendy; Monorama Deb | Zendy

Open Access

Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria

Author(s) -

Srujana Mohanty,

Rajni Gaind,

Rajeev Ranjan,

Monorama Deb

Publication year - 2009

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.493

Subject(s) - cefepime , ceftazidime , etest , cefotaxime , microbiology and biotechnology , beta lactamase , proteus mirabilis , klebsiella pneumoniae , biology , escherichia coli , antibiotics , bacteria , imipenem , antibiotic resistance , biochemistry , genetics , pseudomonas aeruginosa , gene

Extended-spectrum beta-lactamases (ESBLs) may not always be detected in routine susceptibility tests. This study reports the performance of the cefepime-clavulanate ESBL Etest for the detection of ESBLs in Enterobacteriaceae, including those producing AmpC enzyme.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research